The global pharmaceutical industry relies heavily on a consistent supply of high-quality chemical intermediates. 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, identified by CAS number 210963-78-3, is one such compound that plays a crucial role in the synthesis of various APIs. For procurement managers and research scientists, selecting the right supplier for this intermediate is a critical decision that impacts product quality, development timelines, and cost-effectiveness.

Understanding the Product: 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl

This compound, with the molecular formula C10H13ClN2O2 and a molecular weight of 228.67542, is a white powder commonly used in pharmaceutical research and manufacturing. Its specific chemical structure makes it a valuable intermediate in complex synthesis pathways, contributing to the creation of essential pharmaceutical compounds. Ensuring the purity and consistency of this intermediate is vital for its successful application in API production.

Key Criteria for Selecting a Supplier

When evaluating potential suppliers for 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, consider the following criteria:

  • Product Quality and Purity: Verify that the supplier provides detailed specifications, including assay results and impurity profiles. Reputable manufacturers will offer Certificates of Analysis (CoA).
  • Manufacturing Capabilities: Assess the supplier's production capacity, adherence to quality management systems (like GMP), and experience in handling pharmaceutical intermediates.
  • Supply Chain Reliability: A stable and consistent supply chain is essential. Look for suppliers who can demonstrate a track record of timely delivery and responsive customer service.
  • Regulatory Compliance: Ensure the supplier can provide necessary regulatory documentation and adheres to international standards.
  • Pricing and Value: While cost is a factor, it should be balanced against quality and reliability. Seeking quotes from multiple suppliers can help secure competitive pricing.

Why Source from China?

China has become a leading global supplier of pharmaceutical intermediates due to its advanced chemical manufacturing infrastructure and competitive pricing. When you choose a Chinese manufacturer for 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, you are tapping into a vast network of expertise and production capacity. It is crucial to partner with established and reputable companies that prioritize quality and compliance to ensure you buy a product that meets all necessary standards.

Conclusion

The successful procurement of 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl hinges on a careful selection of suppliers. By prioritizing quality, reliability, and regulatory compliance, pharmaceutical companies can ensure a steady supply of this critical intermediate, thereby supporting their manufacturing objectives and contributing to the production of safe and effective medicines. We are committed to being that reliable partner for your sourcing needs.